论文部分内容阅读
目的观察舒降之治疗不稳定型心绞痛的临床疗效。方法48例不稳定型心绞痛患者分为两组-治疗组和对照组。治疗组给予舒降之治疗,对照组用低分子肝索钠,两组均辅以硝酸酯类、钙拮抗剂等药物。结果治疗组总有效率91.7%,对照组总有效率66.7%,治疗组的疗效优于对照组;两组不良反应相比无显著性差异。结论在常规治疗基础上加用舒降之能更有效地控制心绞痛发作,减少心肌梗死、心性猝死的发生,值得临床推广。
Objective To observe the clinical efficacy of Shu-zheng in the treatment of unstable angina pectoris. Methods 48 patients with unstable angina pectoris were divided into two groups - treatment group and control group. The treatment group was given Shuzheng treatment, the control group with low molecular weight heparinate, two groups were supplemented with nitrates, calcium antagonists and other drugs. Results The total effective rate was 91.7% in the treatment group and 66.7% in the control group. The curative effect of the treatment group was better than that of the control group. There was no significant difference between the two groups in adverse reactions. Conclusion On the basis of routine treatment, SHR is more effective in controlling the onset of angina pectoris, reducing the incidence of myocardial infarction and sudden cardiac death, and is worthy of clinical promotion.